In Brief: FDA Cosmetics Twitter; Eyebrow Makeup Sales; Olay ProX Study
This article was originally published in The Rose Sheet
Executive Summary
FDA’s Office of Cosmetics and Colors starts tweeting, NPD says prestige eyebrow makeup sales are an opportunity for growth. More news in brief.
You may also be interested in...
FDA Advances Work On Chemical-Hazard Early-Detection Program
In a recent contract solicitation announcement, FDA’s Center for Food Safety and Applied Nutrition offers insight into its developing “early warning” system for potential chemical hazards in cosmetics, dietary supplements and foods. The agency seeks a contractor with expertise to mine data and identify potential risks based on hazard “signals” across a spectrum of information sources.
China Probe Finds Issues With Nu Skin Compliance, Not Business Model
Nu Skin’s direct-selling model in China, the legality of which some investors have questioned, was not cited in fines levied on the company totaling $540,000. Firm says it “is not aware of any other material enforcement investigations currently pending” in the country, which accounted for nearly half of Nu Skin’s fiscal 2013 fourth-quarter sales.
Olay Professional Pro-X Performs On Par With Top Rx Brand, At Half The Price?
Procter & Gamble is going after consumers who demand a bang for their buck with its wrinkle-targeting Olay Professional Pro-X line, which it claims offers Rx results at a much-reduced price